BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, May 6, 2026
Home » Blogs » BioWorld MedTech Perspectives » Finally, a positive healthcare experience

BioWorld MedTech Perspectives
BioWorld MedTech Perspectives RSS FeedRSS

Medical technology

Finally, a positive healthcare experience

March 1, 2013
By Amanda Pedersen

The Mayo Clinic Jacksonville campus offers a landscaped plaza with garden ponds, walking paths and fountains for patients to enjoy between appointments.

There has never been a shortage of negative news regarding the U.S. healthcare system, and for good reason. I could write a whole book on the subject, just based on my own bad healthcare experiences. But this is a mere 400-word blog, not a book, and I would rather spend it on a positive note.

After suffering from painful digestive problems for far too long, and getting absolutely nowhere with local doctors, I finally took control of my situation and went to the Mayo Clinic in Jacksonville, Florida. It was, hands down, the best healthcare decision I have ever made for myself.

Jacksonville is a six-hour drive each way from where I live and I have had to make several trips back and forth just since Christmas. But the high quality care and attentiveness I have received from the doctors and nurses at Mayo have more than made up for the cost and inconvenience of travel.

From my very first visit on Dec. 26 with my new gastroenterologist to my follow up visit with the colorectal surgeon this past Monday, I noticed a significant difference in the way patients are treated at Mayo compared to any other healthcare facility I have ever been to, which includes both civilian and military hospitals.

I was impressed by my GI doctor’s knowledge about inflammatory bowel disease and its effects on not just the digestive tract but the entire body. He was incredibly thorough in his evaluation and in his explanation of the diagnosis and treatment plan. When it became necessary to send me to one of the clinic’s colorectal surgeons for further treatment, he worked closely with the surgeon to coordinate my care.

Throughout my experience at Mayo I felt confident in the clinic’s team approach to patient care and I was treated like a human being rather than a number. It’s obvious that even the campus itself was designed with patient comfort in mind. In between appointments I took advantage of the outdoor plaza full of garden ponds, walking paths and fountains. And best of all, the entire campus is smoke free so nonsmoking visitors like myself can actually enjoy the fresh Florida air.

I am still frustrated that none of the doctors I saw locally took my medical condition seriously. But I am very glad I took matters into my own hands and went to Mayo. Finally I can eat food again without suffering painful consequences.

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 6, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for May 5, 2026
  • The epidermal growth factor receptor in the inactive (left) and active (right) form.

    Cytospire raises £61M series A to target EGFR in solid tumors

    BioWorld
    Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
  • Strategy compass

    Bio Korea 2026: US policy risks shift to execution framework

    BioWorld
    Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
  • DNA, dollars illustration

    Latus Bio series A financing supports early-stage programs

    BioWorld Science

    Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...

  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing